Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
magazineSilence Therapeutics benefits from innovative gene tech
Important information:
These articles are provided by Shares magazine which is published by AJ Bell Media, a part of AJ Bell. Shares is not written by AJ Bell.
Shares is provided for your general information and use and is not a personal recommendation to invest. It is not intended to be relied upon by you in making or not making any investment decisions. The investments referred to in these articles will not be suitable for all investors. If in doubt please seek appropriate independent financial advice.
Investors acting on the information in these articles do so at their own risk and AJ Bell Media and its staff do not accept liability for losses suffered by investors as a result of their investment decisions.
Issue contents
Big News
- Dollar hits three-year low
- Premier plays down Batchelors sale chatter
- Melrose launches GKN charm offensive
- The winners and losers from Carillion’s demise
- JD says profit will be better than expected
- Savills CEO steps down after nearly 40 years at firm
- Sting in the tail for BP on Deepwater Horizon oil spill
- Dividend downgrades for Card Factory
